An individual who is able to take full advantage of TFSAs may have his first million by age 54. First in a series by Lawrence Solomon for the National Post.
Continue reading Everyone’s a millionaire in Joe Oliver’s revolution
Those who retired at 55 were 89% likelier to die within 10 years of retirement than those who retired at 65.
Continue reading Here’s a retirement plan — don’t
Public health advocates have transformed society in their zeal to promote the greater good. Continue reading Junk Science 2015: Public health’s scary century
Rolling back the government advantages given vaccines would level the R&D playing field and help end the drought in pharmaceutical breakthroughs.
Continue reading Free the pharmaceutical market
Mistakes in novel areas of science inevitably happen, and especially in highly politicized periods where public panic can run high and governments are under the gun.
Continue reading Don’t rush to hand out the Ebola vaccine
The medical-industrial-governmental complex spends more and more but has less and less to show for it.
Continue reading Crippling medical research
Our bodies have changed in the last generation, making us more susceptible than we were a scant few decades ago.
Continue reading We’re more vulnerable to diseases
Pharma giant Merck faces at least two lawsuits alleging wrongdoing over its Measles-Mumps-Rubella (MMR) vaccine — hearings made all the more explosive given the introduction of race into the mix. Continue reading Merck has some explaining to do over their MMR vaccine claims
This response, published by American Thinker, to CPI’s Vaccinating the ‘herd,’ takes issue with several of its statements, particularly in regard to risk factors for children.
Continue reading Clarifying the debate over measles vaccinations
Mass vaccination advocates rely on ‘herd immunity’ to make their case. But it doesn’t exist.
Continue reading Vaccinating the ‘herd’